Skip to main content
TipRanks
Go Ultimate75% OFF

Psyence Biomedical (PBM) Stock Statistics & Valuation Metrics

280 Followers

Total Valuation

Psyence Biomedical has a market cap or net worth of $10.91M. The enterprise value is -$6.08T.

Market Cap
$10.91M
Enterprise Value
-$6.08T

Share Statistics

Psyence Biomedical has 3,814,328 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
3,814,328
Owned by Insiders
―
Owned by Institutions
13.55%

Financial Efficiency

Psyence Biomedical’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -36.81%.

Return on Equity (ROE)
-0.41
Return on Assets (ROA)
-0.39
Return on Invested Capital (ROIC)
-36.81%
Return on Capital Employed (ROCE)
-0.37
Revenue Per Employee
0
Profits Per Employee
-578.04K
Employee Count
12
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Psyence Biomedical is -0.24. Psyence Biomedical’s PEG ratio is -0.00.

PE Ratio
-0.24
PS Ratio
0.00
PB Ratio
0.10
Price to FCF
-0.01
Price to Operating Cash Flow
-0.20
PEG Ratio
-0.00

Income Statement

In the last 12 months, Psyence Biomedical had revenue of 0 and earned -6.94M in profits. Earnings per share was -12.56.

Revenue
0
Gross Profit
-5,266
Operating Income
-6.24M
Pretax Income
-6.94M
Net Income
-6.94M
EBITDA
-6.92M
Earnings Per Share (EPS)
-12.56

Cash Flow

In the last 12 months, operating cash flow was -1.05M and capital expenditures -8, giving a free cash flow of -1.05M billion.

Operating Cash Flow
-1.05M
Free Cash Flow
-1.05M
Free Cash Flow per Share
-15.65

Dividends & Yields

Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-15301.55%
Earnings Yield
-422.88%

Stock Price Statistics

Beta
4.40
52-Week Price Change
-72.37%
50-Day Moving Average
4.46
200-Day Moving Average
3.91
Relative Strength Index (RSI)
41.27
Average Volume (3m)
62.19K

Financial Position

Psyence Biomedical as a current ratio of 14.62, with Debt / Equity ratio of 0.00%

Current Ratio
14.62
Quick Ratio
14.62
Debt to Market Cap
0.00
Net Debt to EBITDA
1.08
Interest Coverage Ratio
-655.06

Taxes

In the past 12 months, Psyence Biomedical has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Psyence Biomedical EV to EBITDA ratio is 1.07, with an EV/FCF ratio of 0.85.

EV to Sales
0.00
EV to EBITDA
1.07
EV to Free Cash Flow
0.85
EV to Operating Cash Flow
0.91

Balance Sheet

Psyence Biomedical has $733.00 in cash and marketable securities with $10.45K in debt, giving a net cash position of -$9,714.00 billion.

Cash & Marketable Securities
$733.00
Total Debt
$10.45K
Net Cash
-$9,714.00
Net Cash Per Share
$0.00
Tangible Book Value Per Share
$0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―